This focus extends to TMC products and services in a range of markets– from interventional cardiology to injection to veterinary care. We deliver a range of solutions, too, covering everything from interventional medicine and pharmaceuticals to medical products and healthcare systems consulting.

Learn more about each TMC business division by clicking the links below:

TERUMO INTERVENTIONAL SYSTEMS (TIS)

TIS is a market leader in providing solutions that enable minimally invasive entry site management, lesion access and therapeutic intervention for cardiology, peripheral arterial disease, embolotherapy and interventional oncology.

TERUMO MEDICAL PRODUCTS (TMP)

TMP designs injection and infusion therapy devices that allow clinicians to deliver the very best day-to-day care to their patients in both the human and animal health markets.

TERUMO HEALTH OUTCOMES (THO)

THO partners with clinicians and hospitals to help them improve patient outcomes, optimize operations and provide process investment guidance that can lead to cost savings. 

PHARMACEUTICAL SOLUTIONS DIVISION (PSD)

PSD offers pharmaceutical and medical device companies worldwide comprehensive product design and development services.

Terumo Americas Holding, Inc. Somerset, NJ

 

Six entities across the business:

• Develops, manufactures and distributes medical devices for cardiac and vascular surgery

• Develops minimally-invasive devices for treatment of vascular diseases in the brain

• Global leader in blood management, blood safety, therapeutic apheresis, cell therapy and cell collections

• Sells intervention and medical products in Latin America, with regional sales in Miami and Puerto Rico

Terumo Bay Area Innovation Laboratory – Campbell, CA

• Product development for Cardiac and Vascular Company, research and development, and pilot and bridge production

• Focused on addressing every segment of the aorta, from the aortic root to the iliac arteries